Tags

Type your tag names separated by a space and hit enter

Use of depo-provera in teens.
J Pediatr Health Care. 1996 Sep-Oct; 10(5):195-201.JP

Abstract

Currently, depot-medroxyprogesterone acetate is the only contraceptive injection available in the United States. Its use was approved by the U.S. Food and Drug Administration in October 1992. This article describes the mechanisms of action, advantages, disadvantages, and contraindications of this very effective contraceptive agent. In addition, the initial workup, the treatment, and the follow-up of the teen receiving depot-medroxyprogesterone acetate are presented.

Authors

No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8920351

Citation

Khoiny, F E.. "Use of Depo-provera in Teens." Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners, vol. 10, no. 5, 1996, pp. 195-201.
Khoiny FE. Use of depo-provera in teens. J Pediatr Health Care. 1996;10(5):195-201.
Khoiny, F. E. (1996). Use of depo-provera in teens. Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners, 10(5), 195-201.
Khoiny FE. Use of Depo-provera in Teens. J Pediatr Health Care. 1996 Sep-Oct;10(5):195-201. PubMed PMID: 8920351.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of depo-provera in teens. A1 - Khoiny,F E, PY - 1996/9/1/pubmed PY - 1996/9/1/medline PY - 1996/9/1/entrez KW - Adolescents KW - Adolescents, Female KW - Age Factors KW - Americas KW - Contraception KW - Contraceptive Agents, Female--beneficial effects KW - Contraceptive Agents, Female--contraindications KW - Contraceptive Agents, Female--side effects KW - Contraceptive Agents, Progestin--beneficial effects KW - Contraceptive Agents, Progestin--contraindications KW - Contraceptive Agents, Progestin--side effects KW - Contraceptive Agents--beneficial effects KW - Contraceptive Agents--contraindications KW - Contraceptive Agents--side effects KW - Contraceptive Effectiveness KW - Contraceptive Mode Of Action KW - Demographic Factors KW - Depo-provera--beneficial effects KW - Depo-provera--contraindications KW - Depo-provera--side effects KW - Developed Countries KW - Family Planning KW - Literature Review KW - Medroxyprogesterone Acetate--beneficial effects KW - Medroxyprogesterone Acetate--contraindications KW - Medroxyprogesterone Acetate--side effects KW - North America KW - Northern America KW - Population KW - Population Characteristics KW - United States KW - Youth SP - 195 EP - 201 JF - Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners JO - J Pediatr Health Care VL - 10 IS - 5 N2 - Currently, depot-medroxyprogesterone acetate is the only contraceptive injection available in the United States. Its use was approved by the U.S. Food and Drug Administration in October 1992. This article describes the mechanisms of action, advantages, disadvantages, and contraindications of this very effective contraceptive agent. In addition, the initial workup, the treatment, and the follow-up of the teen receiving depot-medroxyprogesterone acetate are presented. SN - 0891-5245 UR - https://www.unboundmedicine.com/medline/citation/8920351/Use_of_depo_provera_in_teens_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-5245(96)90001-2 DB - PRIME DP - Unbound Medicine ER -